Morgan Stanley »

Regulus Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $112k 63k 1.79
2024-03-31 $80k 28k 2.88
2022-12-31 $21 15 1.40